Webinars, Pharmaceutical

Nose to Brain Drug Delivery – A Promising Future

Nose to brain drug delivery has considerable potential to address currently unmet needs for CNS therapeutics for the treatment of disorders such as Alzheimer’s, Parkinson’s, and multiple sclerosis.

This webinar discusses the mechanisms of drug delivery to the CNS, device considerations, and formulation ingredients and strategies, including an examination of the pros and cons of liquid vs. powder formulation. By bypassing the blood brain barrier, nose to brain drug delivery offers potential to deliver different drugs and lower doses with minimal systemic effect. The criticality of successful targeting of the olfactory region is noted and the beneficial role of excipients such as mucoadhesives and penetration enhancers is outlined.

Aptar Pharma’s expertise in all aspects of the development and reformulation of drugs for nose to brain delivery is highlighted.

Watch the webinar
Speaker(s): Reenal Gandhi Gemma Budd
22 Apr 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More

This Might Also Be of Interest

3 Jun 2019

Microbial integrity testing for preservative-free drug formulatio...

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
1 Apr 2019

Interview with Guillaume Brouet on Aptar Pharma Services

Publications, Pharmaceutical, Innovation & Insights

Read More
18 Sep 2018

Aptar Pharma provides guidance on FDA regulatory framework for OI...

Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Read More
1 Jun 2018

Connected Medicine: Insights from Payers and Other Stakeholders

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions

Read More
1 11 12 13 14

Request Access

Close

Requesting access to Nose to Brain Drug Delivery – A Promising Future.

  • This field is for validation purposes and should be left unchanged.
Back To Top